About Exoskeletons & Physical Augmentation
The Exoskeletons & Physical Augmentation category is part of the Longevity & Human Enhancement market map, tracking 13 companies building in this segment. Senolytics, epigenetic reprogramming, exoskeletons, nootropics, and implantable devices pushing the boundaries of human lifespan and performance. Curated by Hartmann Capital's venture research team.
Companies in Exoskeletons & Physical Augmentation
- Ekso Bionics — Public, $199M
- ReWalk Robotics — Public, $180M
- Wandercraft — Series C, $171M
- Cyberdyne — Public
- Sarcos (Palladyne AI) — Public, $100M
- German Bionic — Series B, $40M
- Verve Motion — Series B, $35M
- Roam Robotics — Series A, $18M
- Fourier Intelligence — Series D, $83M
- Myomo — Public, $25M
- Esper Bionics — Seed, $5M
- Cionic — Series A, $13M
- Bionik Laboratories — Public, $13M
Frequently Asked Questions
- What companies are in the Exoskeletons & Physical Augmentation category?
- The Exoskeletons & Physical Augmentation category includes 13 companies: Ekso Bionics, ReWalk Robotics, Wandercraft, Cyberdyne, Sarcos (Palladyne AI), German Bionic, Verve Motion, Roam Robotics, Fourier Intelligence, Myomo, Esper Bionics, Cionic, Bionik Laboratories. This is part of the Longevity & Human Enhancement market map maintained by Hartmann Capital.
- How many Exoskeletons & Physical Augmentation startups are tracked?
- Hartmann Capital tracks 13 companies in the Exoskeletons & Physical Augmentation segment of the Longevity & Human Enhancement market map.
- What are the best funded Exoskeletons & Physical Augmentation companies?
- Top funded companies in Exoskeletons & Physical Augmentation include Ekso Bionics ($199M), ReWalk Robotics ($180M), Wandercraft ($171M), Sarcos (Palladyne AI) ($100M), Fourier Intelligence ($83M). Browse the full list in the Longevity & Human Enhancement market map.
- How can I submit my startup?
- You can submit your startup for inclusion by visiting the submission page. Submissions are reviewed by Hartmann Capital's research team.